Interleukin-18-primed human umbilical cord-mesenchymal stem cells achieve superior therapeutic efficacy for severe viral pneumonia via enhancing T-cell immunosuppression

Coronavirus disease 2019 (COVID-19) treatments are still urgently needed for critically and severely ill patients. Human umbilical cord-mesenchymal stem cells (hUC-MSCs) infusion has therapeutic benefits in COVID-19 patients; however, uncertain therapeutic efficacy has been reported in severe patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yan, Fu, Zeqin, Huang, Yinfu, Wu, Shiduo, Wang, Zhen, Ye, Shaotang, Zeng, Weijie, Zeng, Guifang, Li, Duanduan, Yang, Yulin, Pei, Ke, Yang, Jian, Hu, Zhiwei, Liang, Xiao, Hu, Junyuan, Liu, Muyun, Jin, Juan, Cai, Cheguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883134/
https://www.ncbi.nlm.nih.gov/pubmed/36707501
http://dx.doi.org/10.1038/s41419-023-05597-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883134/
https://www.ncbi.nlm.nih.gov/pubmed/36707501
http://dx.doi.org/10.1038/s41419-023-05597-3

Ejemplares similares